List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 51 studies with search of:   "Travoprost"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed 24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed Combination (TTFC) Versus Travoprost When Both Are Given PM in Subjects With Primary Open-Angle Glaucoma (POAG)
Condition: Glaucoma
Intervention: Drug: Travoprost/timolol fixed combination, travoprost
2 Completed Study of Patient Use and Perception of the Travatan Dosing Aid
Condition: Glaucoma
Interventions: Device: Fully Functional Travatan Compliance Monitoring Dispenser;   Device: Partially Functioning Travatan Compliance Monitoring Dispenser;   Device: Non Functioning Travatan Compliance Monitoring Dispenser
3 Terminated Azopt Plus Travatan in Treating Patients With Chronic Angle-Closure Glaucoma (CACG)
Condition: Intraocular Pressure
Interventions: Drug: Travoprost 0.004% + Brinzolamide 1.0%;   Drug: Travoprost 0.004% + Tears Natural
4 Recruiting The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye
Conditions: Glaucoma;   Periocular Skin Pigmentation Changes
Interventions: Drug: Latanoprost;   Drug: Bimatoprost;   Drug: Travoprost
5 Active, not recruiting Value of an Intervention to Enhance Adherence in Glaucoma Patients
Condition: Glaucoma
Interventions: Device: TDA monitor for adherence, travoprost therapy;   Device: TDA and travoprost monotherapy
6 Completed Travatan Versus Timoptic in Treating Open-Angle Glaucoma or Ocular Hypertension
Condition: Glaucoma
Interventions: Drug: Travoprost 0.004% Ophthalmic Solution (Travatan);   Drug: Timolol 0.5% Ophthalmic Solution (Timoptic)
7 Not yet recruiting Effects of Travoprost on Neovascular Glaucoma
Condition: Neovascular Glaucoma
Intervention: Drug: Travoprost
8 Recruiting Phase IV Study of TRAVATAN 0.004% in Subjects With Iris Pigmentation Changes
Conditions: Open-Angle Glaucoma;   Ocular Hypertension
Intervention: Drug: TRAVATAN (travoprost ophthalmic solution) 0.004%
9 Recruiting Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPT
Conditions: Glaucoma;   Ocular Hypertension
Interventions: Drug: Travoprost/Brinzolamide fixed combination;   Drug: Azopt;   Drug: Travatan
10 Completed
Has Results 		Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%
Conditions: Glaucoma;   Ocular Hypertension
Interventions: Drug: bimatoprost 0.03% eye drops;   Drug: travoprost 0.004% eye drops
11 Recruiting Safety and Efficacy of Travoprost/Timolol BAC-Free
Conditions: Open-Angle Glaucoma;   Ocular Hypertension
Interventions: Drug: Travoprost 0.004%/Timolol 0.5%;   Drug: Travoprost 0.004%/Timolol 0.5% BAC-free
12 Recruiting Phase IV Randomised Double-Masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
Conditions: Open-Angle Glaucoma;   Ocular Hypertension
Interventions: Drug: Travoprost 0.004% / Timolol maleate 0.5%;   Drug: Travoprost 0.004% / Timolol maleate 0.5%
13 Completed Safety and IOP Lowering Efficacy of AL-6221
Conditions: Open-Angle Glaucoma;   Ocular Hypertension
Interventions: Drug: AL-6221;   Drug: TRAVATAN QD;   Drug: Placebo
14 Completed Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy
Condition: Glaucoma
Intervention: Drug: Travatan-Z
15 Completed A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)
Conditions: Glaucoma, Open-Angle;   Ocular Hypertension
Interventions: Drug: Travoprost;   Drug: Latanoprost
16 Recruiting A Single Dose Comfort Comparison of Travoprost Bak Free 0.004% in One Eye Versus Latanoprost 0.005% in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
Conditions: Open-Angle Glaucoma;   Ocular Hypertension
Intervention: Drug: Travoprost
17 Completed IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension
Conditions: Open-Angle Glaucoma;   Ocular Hypertension
Intervention: Drug: Travoprost/brinzolamide
18 Completed A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension
Conditions: Glaucoma;   Ocular Hypertension
Intervention: Drug: Travoprost, Brinzolamide, Dorzolamide/timolol combo
19 Completed A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma
Conditions: Glaucoma, Angle-Closure;   Ocular Hypertension
Interventions: Drug: Travoprost (0.004%);   Drug: Latanoprost (0.005%)
20 Active, not recruiting Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-Angle Glaucoma (OAG)
Conditions: Open-Angle Glaucoma;   Ocular Hypertension
Intervention: Drug: bimatoprost 0.03%, latanoprost 0.005%, and travoprost 0.004%

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services